Recommended Issuance of Bonus Shares, subject to shareholders approval and any other applicable regulatory and statutory approval, in ratio of 1:4 i.e. 1(one) new fully paid up Equity Shares ....

Filed: 03 Sep 2026, 12:14 IST Exchange: BSE Category: Corporate Action — Bonus Issue

Bonus shares recommended at 1:4 ratio, subject to shareholder approval - Bonus shares to be issued from securities premium and/or free reserves - Authorized share capital increase from Rs 10.00 Cr to Rs 10.40 Cr, subject to approval - Record date for bonus issue to be announced later - Bonus shares expected to be credited by Nov 3, 2026 - AGM scheduled for Sep 29, 2026; cut-off and record date for voting and dividend Sep 22, 2026 - Independent Director Mr. Rohit Jain reappointment recommended from Sep 30, 2026 for 5 years

Source: Original filing PDF — view on exchange portal

⚡ You're reading this after the fact — subscribers got it instantly

ISA

Indian Stock Alerts BOT

🚨 524717 — Quarterly Results

Revenue: ₹2,35,800 Cr (+12% YoY)

PAT: ₹19,200 Cr (+17% YoY)

EBITDA margin: 16.8%

Board declared ₹10/share dividend. Jio adds 8M subs.

📎 bseindia.com/xml-data/...

🎧 Audio summary ready

✓✓ 6:47 PM

🎧

Instant audio summaries2-min AI concall recap delivered with every earnings alert

📊

20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings

🔍

Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically

⚡

Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add 524717 to your watchlist — all of this, automated.

14-day Pro trial · No credit card · Cancel anytime

More on Titan Biotech Ltd

Important. The summary above is generated automatically from Titan Biotech Ltd's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.